No Data
Yuexin Health: 2024 Annual Results Forecast
Everjoy Health Group (002162.SZ): Expected loss of 0.135 billion yuan to -0.165 billion yuan for the year 2024.
On January 23, GELONGHUI reported that Everjoy Health Group (002162.SZ) announced its performance forecast for 2024, with a projected net income loss attributable to shareholders of the listed company of 0.135 billion to 0.165 billion yuan, turning from profit to loss year-on-year; after deducting non-recurring gains and losses, the net income loss is expected to be between 0.16 billion and 0.19 billion yuan; basic EPS is expected to be a loss of 0.15 to 0.18 yuan per share; revenue is projected to be between 1.1 billion and 1.3 billion yuan. During the reporting period, competition in the construction ceramics industry intensified, demand growth slowed, and product price competition was fierce. Although the company’s tile product sales increased compared to the same period last year, affected by
Everjoy Health Group (002162.SZ) has appointed Ding Hui as the president.
Everjoy Health Group (002162.SZ) announced that the company's Board of Directors recently received a proposal from the company's director and president, Mr. Yu Jing...
Everjoy Health Group (SZSE:002162) Is Carrying A Fair Bit Of Debt
Revenues Not Telling The Story For Everjoy Health Group Co., Ltd. (SZSE:002162) After Shares Rise 32%
Everjoy Health Group (002162.SZ): There are currently no major expansion plans in the assisted reproduction business.
Gelonghui November 5th | Everjoy Health Group (002162.SZ) stated on the investor interaction platform that the company is actively promoting health care business with the "medical care, support, health, education, and research" integrated industrial model, currently no major expansion plans in the assisted reproduction business.
Is Everjoy Health Group (SZSE:002162) Using Too Much Debt?
